Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 34 holding rows worth $2,043,110,000.

Accession
0001654954-18-001508
Filed
2018-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 34 entries on the cover page, a total value of $2,043,110,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,043,110,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,500,000$400,290,000thousands by filing dateput
NEKTAR THERAPEUTICS640268108COM3,350,000$200,062,000thousands by filing date
HCA Healthcare Inc40412C101COM1,250,000$109,800,000thousands by filing date
MYLAN NVN59465109SHS EURO2,500,000$105,775,000thousands by filing date
ALLERGAN PLCG0177J108SHS600,000$98,148,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock780,000$88,413,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock5,750,000$87,170,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM2,500,000$86,400,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM2,458,100$84,067,000thousands by filing date
TESARO INC881569107COM850,000$70,440,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM6,500,000$63,050,000thousands by filing date
BIOVERATIV INC09075E100COM1,096,000$59,096,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR3,000,000$56,850,000thousands by filing datecall
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR1,500,000$53,205,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock1,000,000$52,540,000thousands by filing dateput
MYRIAD GENETICS INC62855J104COM1,500,000$51,518,000thousands by filing date
MEDICINES CO584688105COM1,600,000$43,744,000thousands by filing date
ENDOLOGIX INC29266S106COM8,000,000$42,800,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM600,000$40,800,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM2,650,000$35,113,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW1,000,000$31,770,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM800,000$31,480,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM500,000$27,350,000thousands by filing date
ALKERMES PLCG01767105SHS400,000$21,892,000thousands by filing date
INVITAE CORP46185L103COM2,398,123$21,775,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM300,000$16,692,000thousands by filing date
K2M GROUP HLDGS INC48273J107COM850,000$15,300,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS575,000$12,765,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock535,500$9,693,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM1,000,000$9,030,000thousands by filing date
BIOSCRIP INC09069N108COM2,540,200$7,392,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock125,000$4,686,000thousands by filing date
Mallinckrodt PlcG5785G107SHS105,000$2,369,000thousands by filing date
SURGERY PARTNERS INC86881A100COM135,084$1,635,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-18-001508this filing2018-02-14acceptance time not in the bulk data set